Status:

COMPLETED

A Study on Efficacy and Safety of Topiramate in Maintaining Weight Loss in Obese Patients Following an Intensive, Non-Pharmacologic Weight Loss Program

Lead Sponsor:

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Conditions:

Obesity

Eligibility:

All Genders

18-75 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to compare the efficacy and safety of topiramate 96mg and 192mg daily) with placebo in the treatment of obesity following an intensive non-pharmacologic weight loss progra...

Detailed Description

Although dietary modification coupled with increased exercise is the preferred treatment of obesity, these lifestyle changes alone are often insufficient in achieving and maintaining weight reduction ...

Eligibility Criteria

Inclusion

  • Body Mass Index (BMI) \>= 33 and \< 50 kg/m2
  • BMI \>=30 and \< 50 kg/m2 if patients have controlled hypertension or abnormal blood lipids
  • Stable weight
  • Female patients must be postmenopausal for at least 1 year, surgically incapable of childbearing, practicing abstinence, or practicing an acceptable method of contraception (requires negative pregnancy test)
  • Randomization criteria: Weight reduction of more than 8% of enrollment body weight during the eight week run-in phase

Exclusion

  • Prior exposure, known contraindication, or hypersensitivity to topiramate
  • Exposure to any other experimental drug or device within last 30 days
  • A diagnosis of diabetes (except those diagnosed during the enrollment if no medications are needed)
  • History or evidence of clinically significant liver disease, cardiovascular disease, uncontrolled hypertension or high thyroid levels
  • History of obesity with known cause
  • History or family history of kidney stones
  • History of weight loss surgery or liposuction
  • History of malignancy within last 5 years
  • History of an eating disorder

Key Trial Info

Start Date :

August 1 2000

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2002

Estimated Enrollment :

561 Patients enrolled

Trial Details

Trial ID

NCT00236600

Start Date

August 1 2000

End Date

June 1 2002

Last Update

April 28 2010

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.